Pharmacokinetic and pathophysiologic covariates influencing treatment outcomes with T-DM1 in patients with HER2-positive metastatic breast cancer (MBC).
Gupta M, LoRusso P, Burris H, Wang B, Joshi A, Tong Y, Chu Y, Girish S. Pharmacokinetic and pathophysiologic covariates influencing treatment outcomes with T-DM1 in patients with HER2-positive metastatic breast cancer (MBC). Journal Of Clinical Oncology 2011, 29: 633-633. DOI: 10.1200/jco.2011.29.15_suppl.633.Peer-Reviewed Original Research